Exousia Bio, Inc. financial data

Symbol
LMMY on OTC
Location
St. Petersburg, FL
Fiscal year end
31 May
Latest financial report
10-Q - Q4 2025 - 17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0% % -100%
Debt-to-equity 1.4% %
Return On Equity -1.4% % 99%
Return On Assets -1374% % -657%
Operating Margin -711% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73,500,000 shares 845%
Common Stock, Shares, Outstanding 70,000,000 shares 800%
Entity Public Float $1,289,023 USD
Common Stock, Value, Issued $7,000 USD 800%
Weighted Average Number of Shares Outstanding, Basic 16,764,767 shares 116%
Weighted Average Number of Shares Outstanding, Diluted 16,764,767 shares 116%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD -100%
Cost of Revenue $62,108 USD
General and Administrative Expense $28,380 USD 1.1%
Operating Income (Loss) $237,005 USD -3495%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $75,720 USD -214%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $75,720 USD -214%
Earnings Per Share, Basic -0.01 USD/shares -200%
Earnings Per Share, Diluted -0.01 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Assets, Current $0 USD -100%
Property, Plant and Equipment, Net $670 USD -72%
Intangible Assets, Net (Excluding Goodwill) $0 USD -100%
Other Assets, Noncurrent $22,050,000 USD
Assets $22,051 USD -11%
Accounts Payable, Current $212,302 USD
Accrued Liabilities, Current $0 USD -100%
Liabilities, Current $261,023 USD
Liabilities $261,023 USD
Retained Earnings (Accumulated Deficit) $288,623 USD -8349%
Stockholders' Equity Attributable to Parent $35,314 USD 40%
Liabilities and Equity $22,051 USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,500 USD
Net Cash Provided by (Used in) Financing Activities $3,500 USD
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 75,000,000 shares -25%
Common Stock, Shares, Issued 70,000,000 shares 800%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 USD -100%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $0 USD -100%
Depreciation $99 USD -99%
Deferred Tax Assets, Operating Loss Carryforwards $0 USD -100%
Preferred Stock, Shares Authorized 0 shares
Additional Paid in Capital $22,071 USD -20%
Deferred Tax Assets, Net of Valuation Allowance $0 USD